FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.


FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2012 May 15;85(10):950.

Corrections

The article, “End-Stage Renal Disease: Symptom Management and Advance Care Planning” (April 1, 2012, page 705), contained two errors. In Table 3 on page 708, the dosage for fentanyl was incorrectly listed as 12.5 mg. The correct dosage for fentanyl is 12.5 mcg intravenously or subcutaneously every two hours as needed. The brand name Duragesic was also incorrectly added to fentanyl in Table 3, and in several locations throughout the article. Fentanyl should have been listed without a brand name. The online version of this article has been corrected.



Copyright © 2012 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Information From Industry

More in Pubmed

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article